← Back to Vaccine Database

VXA-CoV2-1 Ad5 adjuvanted Oral Vaccine platform

Viral vector (Non-replicating) vaccine · VDDBV0834

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04563702 Phase 1COVID-19
NCT05067933 Phase 2COVID-19